Clinical drug investigation

Ketamine and Changes in Brain Adaptability

Updated

Abstract

Ketamine may initiate neuroplastic changes within hours to days, leading to rapid antidepressant effects.

  • Ketamine primarily acts by blocking the NMDA receptor, which triggers a series of signaling events in the brain.
  • These events promote synaptic plasticity and neurogenesis, contributing to quick relief from depressive symptoms.
  • Preclinical evidence shows that ketamine influences BDNF signaling, activates the mTOR pathway, and modulates AMPA receptors.
  • Clinical studies indicate that the timing of ketamine's antidepressant effects correlates with these biological changes.
  • The review highlights the need for further research to bridge gaps between preclinical findings and clinical outcomes.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declarations. Conflicts of Interest: The author declares no conflicts of interest. Ethical Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Code Availability: Not applicable. Availability of Data and Materials: No datasets were generated or analyzed during the current study. Author Contributions: Angel Prabakar is the sole author of this manuscript and takes full responsibility for its content. The author has read and approved the final version and agrees to be accountable for all aspects of the work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free